Is Cardiometabolic Risk Screening Redundant for MASLD Diagnosis in Adults With Type 1 Diabetes Mellitus? A Call for Action

Is Cardiometabolic Risk Screening Redundant for MASLD Diagnosis in Adults With Type 1 Diabetes Mellitus? A Call for Action

Mantovani, Alessandro;Morandin, Riccardo;Targher, Giovanni
Writing – Original Draft Preparation
2026-01-01

Abstract

Is Cardiometabolic Risk Screening Redundant for MASLD Diagnosis in Adults With Type 1 Diabetes Mellitus? A Call for Action
2026
CAP
FibroScan
MASLD
T1DM
hepatic steatosis
metabolic dysfunction‐associated steatotic liver disease
type 1 diabetes
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1207771
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact